Complicated Skin And Soft Tissue Infections Clinical Trials | A Drug Pipeline Analysis Report 2023 Companies – Stempeutics, Angiocrine Bioscience, Carephar

Complicated Skin And Soft Tissue Infections Clinical Trials | A Drug Pipeline Analysis Report 2023 Companies – Stempeutics, Angiocrine Bioscience, Carephar

June 07
14:00 2023
Complicated Skin And Soft Tissue Infections Clinical Trials | A Drug Pipeline Analysis Report 2023 Companies - Stempeutics, Angiocrine Bioscience, Carephar
DelveInsight Business Research LLP
(Nevada, Las Vegas United States) DelveInsight’s “Complicated Skin And Soft Tissue Infections- Pipeline Insight, 2023” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Complicated Skin And Soft Tissue Infections pipeline landscape.

Key Takeaways from the Complicated Skin And Soft Tissue Infections Pipeline Report

  • Over 5+ companies and 5+ pipeline drugs in Alpha1-Antitrypsin Deficiency (AATD) pipeline landscape and their anticipated acceptance in the Complicated Skin And Soft Tissue Infections market would significantly increase market revenue. 

  • Leading Complicated Skin And Soft Tissue Infections companies developing novel drug candidates to improve the Complicated Skin And Soft Tissue Infections treatment landscape include Stempeutics, Angiocrine Bioscience, CarepharOssium Health and others.

  • Promising Complicated Skin And Soft Tissue Infections pipeline therapies in various stages of development include Mitapivat and others 

Complicated Skin And Soft Tissue Infections Overview

A Complicated Skin And Soft Tissue Infections is a small tunnel that develops between the end of the bowel and the skin near the anus (where poo leaves the body). They’re usually the result of an infection near the anus causing a collection of pus (abscess) in the nearby tissue. When the pus drains away, it can leave a small channel behind. Complicated Skin And Soft Tissue Infectionss can cause unpleasant symptoms, such as discomfort and skin irritation, and will not usually get better on their own. Surgery is recommended in most cases. 

Symptoms of an Complicated Skin And Soft Tissue Infections can include skin irritation around the anus, a constant, throbbing pain that may be worse when a person sits down, move around, poo or cough, smelly discharge from near the anus, passing pus or blood when a person has to poo, swelling and redness around the anus and a high temperature (fever) if the person also have an abscess. Most Complicated Skin And Soft Tissue Infectionss develop after an anal abscess. One can get one if the abscess does not heal properly after the pus has drained away. Less common causes of Complicated Skin And Soft Tissue Infectionss include Crohn’s disease, diverticulitis, hidradenitis suppurativa, infection with tuberculosis (TB) or HIV, or a complication of surgery near the anus. 

Complicated Skin And Soft Tissue Infections  Pipeline Analysis: Drug Profile

Stempeucel: Stempeutics

Stempeucel is a flagship product. It is an on-demand, off-the-shelf product based on pooled, allogeneic Mesenchymal Stromal Cells derived from the bone marrow of healthy, adult volunteers. In August 2020, the Drug Controller General of India (DCGI) granted manufacturing and marketing approval for Stempeucel product for the treatment of CLI due to Buerger’s Disease and CLI due to Atherosclerotic Peripheral Arterial Disease. Stempeucel® becomes the first allogeneic cell therapy product to be approved for commercial use in India and the first stem cell product to be approved Globally for CLI indication. Stempeucel® is being developed for the treatment of Knee Osteoarthritis, Diabetic Foot Ulcer, PeriComplicated Skin And Soft Tissue Infections (PAF), and Acute Respiratory Distress Syndrome due to COVID-19 pneumonia. An open-label, single-arm, investigator-initiated Phase I/II study to assess the safety and efficacy of local administration of Stempeucel® in Patients with perianal fistulizing Crohn’s disease.

Discover more about the emerging Complicated Skin And Soft Tissue Infections drugs @ Complicated Skin And Soft Tissue Infections Treatment Drugs

Complicated Skin And Soft Tissue Infections Pipeline Therapies and Key Companies

  • Stempeucel: Stempeutics

And others 

DelveInsight’s Report covers around 5+ products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I) along with the details of

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

Alpha1-Antitrypsin Deficiency (AATD) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

 

  • Intra-articular

  • Intraocular

  • Intrathecal

  • Intravenous

  • Ophthalmic

  • Oral

  • Parenteral

  • Subcutaneous

  • Topical

  • Transdermal

 

Products have been categorized under various Molecule types such as

 

  • Oligonucleotide

  • Peptide

  • Small molecule

Drugs have been categorized under various product types like mono, Combination, and Mono/Combination.

Scope of the Complicated Skin And Soft Tissue Infections  Pipeline Report 

  • Coverage: Global 

  • Key Alpha1 Antitrypsin Deficiency Companies:  Stempeutics, Angiocrine Bioscience, Carephar, Ossium Health, and others.

  • Key Complicated Skin And Soft Tissue Infections  Pipeline Therapies: Stempeucel and others 

Find out more about the Complicated Skin And Soft Tissue Infections treatment options in development @ Complicated Skin And Soft Tissue Infections Clinical Trials

Table of Contents

1. Complicated Skin And Soft Tissue Infections Introduction

2. Complicated Skin And Soft Tissue Infections Executive Summary

3. Complicated Skin And Soft Tissue Infections Overview

4. Complicated Skin And Soft Tissue Infections Pipeline Therapeutics

5. Complicated Skin And Soft Tissue Infections Late-Stage Products (Phase III)

6. Complicated Skin And Soft Tissue Infections Mid-Stage Products (Phase  II)

7. Complicated Skin And Soft Tissue Infections Early Stage Products (Phase  I/II)

8. Complicated Skin And Soft Tissue Infections Preclinical Stage Products

9. Complicated Skin And Soft Tissue Infections Discovery Stage Products

10. Complicated Skin And Soft Tissue Infections Therapeutic Assessment

11. Complicated Skin And Soft Tissue Infections Inactive Products

12. Complicated Skin And Soft Tissue Infections Collaborations Assessment- Licensing / Partnering / Funding

13. Complicated Skin And Soft Tissue Infections Unmet Needs

14. Complicated Skin And Soft Tissue Infections Market Drivers and Barriers

15. Appendix

16. About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Categories